| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.6 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.6 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |